首页|左西孟旦注射液联合常规药物治疗慢性心力衰竭患者的效果

左西孟旦注射液联合常规药物治疗慢性心力衰竭患者的效果

扫码查看
目的:观察左西孟旦注射液联合常规药物治疗慢性心力衰竭(CHF)患者的效果.方法:选取 2021 年 5 月至 2023 年 5 月该院收治的 102 例CHF患者进行前瞻性研究,按照随机数字表法分为观察组与对照组各 51 例.对照组采用常规药物治疗,观察组在对照组基础上联合左西孟旦注射液治疗,比较两组治疗总有效率、心功能指标[左心室射血分数(LVEF)、左心室舒张末期内径(LVEDD)]水平、血清心肌损伤指标[脑钠肽(BNP)、心肌肌钙蛋白I(cTnI)、同型半胱氨酸(Hcy)]水平、血清炎性因子[超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)]水平和不良反应发生率.结果:观察组治疗总有效率为 88.24%,高于对照组的 72.55%,差异有统计学意义(P<0.05);治疗 2、4 周后,两组LVEF水平均高于治疗前,且观察组高于对照组,两组LVEDD水平和血清BNP、cTnI、Hcy、hs-CRP、IL-6水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:左西孟旦注射液联合常规药物治疗CHF患者可提高治疗总有效率,改善心功能指标水平,降低心肌损伤指标和炎性因子水平,效果优于单纯常规药物治疗.
Effects of Levosimendan injection combined with conventional drugs in treatment of patients with chronic heart failure
Objective:To observe effects of Levosimendan injection combined with conventional drugs in treatment of patients with chronic heart failure(CHF).Methods:A prospective study was conducted on 102 patients with CHF admitted to this hospital from May 2021 to May 2023.According to the random number table method,they were divided into observation group and control group,51 cases in each group.The control group was treated with conventional drugs,while the observation group was treated with Levosimendan injection on the basis of that of the control group.The total effective rate,the cardiac function indexes[left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDD)]levels,the serum myocardial injury indexes[brain natriuretic peptide(BNP),cardiac troponin-I(cTnI),homocysteine(Hcy)]levels,the serum inflammatory factors[high-sensitivity C-reactive protein(hs-CRP),interleukin-6(IL-6)]levels,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 88.24%,which was higher than 72.55%of the control group,and the difference was statistically significant(P<0.05).After 2 weeks and 4 weeks of treatment,the LVEF levels of the two groups were higher than those before the treatment,and those in the observation group were higher than those in the control group;the levels of LVEDD and serum BNP,cTnI,Hcy,hs-CRP and IL-6 in the two groups were lower than those before the treatment,and those in the observation group were lower than those in the control group;and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Levosimendan injection combined with conventional drugs in the treatment of the CHF patients can improve the total effective rate of treatment,improve the levels of cardiac function indexes,and reduce the levels of myocardial injury indexes and inflammatory factors.Moreover,it is superior to single conventional drug therapy.

Chronic heart failureLevosimendanCardiac functionMyocardial injuryInflammatory factorAdverse reaction

李芳

展开 >

济源市第二人民医院心内科,河南 济源 459000

慢性心力衰竭 左西孟旦 心功能 心肌损伤 炎性因子 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(5)
  • 7